Sun Pharmaceutical Industries’ subsidiary -- TARO Pharmaceuticals Inc. has completed 100% acquisition of Antibe Therapeutics Inc., Canada for a total consideration of CAD 4.5 million. Earlier, TARO Pharmaceuticals Inc. had entered into an agreement with Antibe Therapeutics Inc., Canada, pursuant to which Sun Pharma had agreed to acquire 100% stake in Antibe Therapeutics Inc.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
